Focused R&D Pipeline: Takeda invests heavily in research and development across its core therapeutic areas, leading to a robust pipeline of potential new therapies and extending the lifecycle of existing products.

Leadership in Rare Diseases: The company holds a strong market position and extensive expertise in developing and commercializing treatments for rare diseases, a segment characterized by high unmet medical need and fewer competitors.

Strategic Therapeutic Focus: Takeda concentrates its efforts on five key areas – Gastroenterology, Rare Diseases, Plasma-Derived Therapies, Oncology, and Neuroscience – allowing for deep specialization and efficient resource allocation.